Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico

Abstract

Background. Approximately 180 million persons (∼2.8%) globally are estimated to be infected by hepatitis C virus (HCV). HCV prevalence in Mexico has been estimated to be between 1.2 and 1.4%. The aim of present work was to determine the prevalence of HCV infection in patients and family members attending two primary care clinics in Puebla, Mexico.Material and methods. Patients and their accompanying family members in two clinics were invited to participate in this study between May and September 2010.Results. A total of 10,214 persons were included in the study; 120 (1.17%) persons were anti-HCV reactive. Of the reactive subjects, detection of viral RNA was determined in 114 subjects and 36 were positive (31%). The more frequent risk factors were having a family history of cirrhosis (33.1%) and having a blood transfusion prior to 1995 (29%). After a multiple logistic regression analysis only transfusion prior to 1995 resulted significant to HCV transmission (p = 0.004). The overall detected HCV genotypes were as follows: 1a (29%), 1b (48.5%), 2/2b (12.8%), and 3a (6.5%).Conclusion. The HCV prevalence in this population is in agreement with previous studies in other regions of Mexico.

Keywords

• HCV prevalence
• Anti-HCV antibodies
• HCV genotypes